Aurobindo Pharma Limited (NSE:AUROPHARMA)
India
· Delayed Price · Currency is INR | Market Cap | 658.28B |
| Revenue (ttm) | 309.22B |
| Net Income (ttm) | 34.91B |
| Shares Out | 580.80M |
| EPS (ttm) | 59.81 |
| PE Ratio | 18.95 |
| Forward PE | 15.56 |
| Dividend | 3.00 (0.26%) |
| Ex-Dividend Date | n/a |
| Volume | 1,165,909 |
| Average Volume | 1,769,398 |
| Open | 1,138.00 |
| Previous Close | 1,134.70 |
| Day's Range | 1,119.30 - 1,152.80 |
| 52-Week Range | 1,010.00 - 1,592.00 |
| Beta | 0.54 |
| RSI | 50.66 |
| Earnings Date | May 28, 2025 |
About Aurobindo Pharma
Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibi... [Read more]
Financial Performance
In 2023, Aurobindo Pharma's revenue was 290.02 billion, an increase of 16.68% compared to the previous year's 248.55 billion. Earnings were 31.73 billion, an increase of 64.62%.
Financial StatementsNews
Aurobindo Pharma gains over 2.5% after USFDA nod for Rivaroxaban tablets in $8.5 billion US market
Shares of Aurobindo Pharma were trading higher in early trade on April 15, 2025, after the company received final approval from the US Food and Drug Administration (USFDA) for its Rivaroxaban tablets,...
Top stocks to watch today, April 15: HDFC Bank, Tata Power, Cyient, IRCON, Vedanta, Aurobindo Pharma and more
Indian stock markets are set to reopen today after an extended weekend, with investors watching closely to see if the bullish momentum from the last session continues. On Friday, benchmark indices reg...
Stocks to watch today: Zydus, Aurobindo, HCL Tech, Tata Power, Indian Hotels, Cyient in focus on expansion and global deals
Stocks of several companies are expected to remain in the spotlight today following a series of announcements related to international expansion, regulatory approvals, and strategic partnerships. Zydu...
Aurobindo Pharma subsidiary receives 11 USFDA observations after North Carolina facility inspection
Aurobindo Pharma Limited has announced the completion of a United States Food and Drug Administration (USFDA) inspection at its Raleigh, North Carolina facility, operated by Aurolife Pharma LLC, a who...
Aurobindo Pharma shares surge over 3% as subsidiary CuraTeQ Biologics reports successful trial results for bone drug BP16
Shares of Aurobindo Pharma jumped 3.69% to ₹1,097.05 on Friday after its biologics arm, CuraTeQ Biologics, announced successful Phase 1 trial results for BP16 — a biosimilar version of denosumab (mark...
Top stocks to watch today, April 11: Tata Steel, Infosys, TCS, BHEL, Aurobindo Pharma, Biocon and more
The Indian stock market could open on a negative note today (Friday, April 11), as indicated by Gift Nifty. At 8:27 AM, Gift Nifty was seen trading at 22,934, down 0.48%. The Indian stock market may o...
Pharma Stocks Falls: Aurobindo Pharma slips 2%, Lupin down 2%, Divi’s Labs falls 3% as Trump reiterates tariffs on pharmaceuticals ‘soon’
Indian pharmaceutical stocks declined in early trade on Wednesday following renewed concerns over potential U.S. import tariffs. At 9:36 AM, Aurobindo Pharma shares were down 2% to ₹1,073.15, Dr. Redd...
Aurobindo Pharma subsidiary secures EU approval for Dyrupeg, a pegylated filgrastim biosimilar
Aurobindo Pharma has achieved a significant milestone with the European Commission (EC) granting marketing authorization for Dyrupeg™, a pegylated filgrastim biosimilar, in the European Union (EU). Th...
Pharma Stocks Falls: Aurobindo Pharma slips 8.06%, Lupin down 6.72%, Divi’s Labs falls 5.94% as Trump hints at pharma import tariffs
Indian pharmaceutical stocks came under intense pressure in morning trade on April 4, 2025, after former US President Donald Trump hinted at imposing sweeping tariffs on pharmaceutical imports. His st...
Pharma sector: High US exposure puts Indian pharma stocks like Natco, Aurobindo, Dr Reddy’s, Lupin on edge amid Trump tariff threat
As the Trump administration intensifies its trade stance with the unveiling of fresh tariff threats, Indian pharmaceutical companies with high US revenue exposure have come under the spotlight. The ph...
Aurobindo Pharma shares jump over 7% as Trump exempts pharma exports from reciprocal tariff
Shares of Aurobindo Pharma surged 7.36% to ₹1,243.10 in early trade on April 3 after the U.S. administration confirmed that pharmaceutical products will be exempt from the newly announced 26% reciproc...
Pharma stocks surge as Trump tariffs spare sector; Aurobindo (+8.1%), Dr Reddy’s (+6.2%), Lupin (+4.9%) lead rally on tariff relief
Indian pharma stocks were among the top gainers on Thursday morning after the sector was excluded from the newly announced reciprocal tariffs by the Trump administration. The sharp rally reflects reli...
Pharma stocks like Zydus Life, Lupin, Aurobindo Pharma, Dr Reddy’s Lab to rally as Trump exempts tariffs on pharma for now
Pharma stocks are poised for a relief rally after US President Donald Trump exempted the pharma sector from tariffs.
Sun Pharma, Dr. Reddy’s, Welspun India, Bharat Forge, Lupin, Biocon, UPL, Aurobindo, Indo Count, Cummins India and over 100 other Indian companies could face major impact from 26% US tariff hike
In a major escalation of trade tensions, US President Donald Trump on April 2 announced a 26% reciprocal tariff on imports from India, citing high tariffs imposed by India on American goods. The move ...
Aurobindo Pharma: US FDA classifies inspection at Apitoria Pharma Unit V as ‘Voluntary Action Indicated’
Aurobindo Pharma Ltd. announced that the U.S. Food and Drug Administration (US FDA) has classified the inspection at its wholly owned subsidiary, Apitoria Pharma Private Limited’s Unit V, as “Voluntar...
Aurobindo arm ends vaccine license agreement with Hilleman Labs
Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman Laboratories Singapore Pte Ltd t.
Aurobindo Pharma terminates vaccine license agreement with Hilleman Laboratories
Aurobindo Pharma Limited has announced the termination of its License Agreement with Hilleman Laboratories Singapore Pte. Limited through its wholly owned step-down subsidiary, Auro Vaccines Private L...
Stocks to watch today: AstraZeneca, Glenmark, Aurobindo Pharma, Mankind Pharma, Bayer Crop in pharma updates
The pharmaceutical sector saw a mix of regulatory approvals and tax-related issues. Key Highlights AstraZeneca: Received approval from the Central Drugs Standard Control Organisation to import a lung ...
Aurobindo Pharma USA’s warehouse receives OAI status with five observations from US FDA
Aurobindo Pharma USA Inc., a 100% subsidiary of Aurobindo Pharma, recently underwent an inspection by the United States Food and Drug Administration (US FDA) at its East Windsor, New Jersey, warehouse...
Pharma stocks drop up to 7% after Trump announces 25% tariff on imports
Shares of Indian pharmaceutical companies fell sharply on Wednesday after former U.S. President Donald Trump announced plans to impose a 25% tariff on imported pharmaceuticals, aiming to boost domesti...
Aurobindo shares fall 7% as US FDA issues 5 observations on pre-approval inspection for Andhra unit
Shares of Aurobindo Pharma fell by 7% to ₹1,098.10 after the company disclosed that the U.S. Food and Drug Administration (US FDA) had issued five observations for its step-down subsidiary Eugia Steri...
US FDA completes action with 5 observations for Aurobindo Pharma’s Eugia Steriles facility
Aurobindo Pharma’s Eugia Steriles Facility Completes US FDA Pre-Approval Inspection with Five Observations Aurobindo Pharma Limited announced that its step-down subsidiary, Eugia Steriles Private Limi...
Pharma stocks rally: Aurobindo Pharma up 4.05%, Lupin jumps 3.81%, Biocon gains 2.80% at market open
Pharmaceutical stocks opened on a strong note on Tuesday, with several leading companies witnessing sharp gains. Aurobindo Pharma surged 4.05% to ₹1,190.95, leading the sectoral rally and attracting s...
Aurobindo Pharma’s API Unit 2 in Telangana receives VAI classification from US FDA, EIR issued
Aurobindo Pharma announced that its API manufacturing Unit 2, located in Gaddapotharam Village, Telangana, has been classified as “Voluntary Action Indicated” (VAI) by the US Food and Drug Administrat...
Aurobindo Pharma subsidiary’s facility receives EIR from US FDA with VAI classification
Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) has completed its inspection of Unit-2, an API manufacturing facility of its wholly owned subsidiary, Apitoria P...